• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏和大脑中强心苷的浓度(作者译)

[Concentration of cardiac glycosides in the heart and brain (author's transl)].

作者信息

Flasch H, Heinz N

出版信息

Arzneimittelforschung. 1976;26(6):1213-6.

PMID:989419
Abstract

In cats the concentration of cardio-active glycosides in the heart and brain were investigated with trititum-labelled substances. Steady-state conditions were achieved by repeated i.v. injections of ouabain, digoxin, beta-methyldigoxin, digitoxin, and oleandrin over 5 days. 5 h after the last application glycoside concentrations were measured in plasma, urine, heart, cerebrum and cerebellum. Furthermore the metabolic pattern in these compartments was determined. 1. The glycoside concentration in the heart per g wet weight ranges only from 0.93 (oleandrin) to 1.88% (ouabain) of the daily administered dose per kg. 2. The concentrations in the brain show much higher differences between the diverse glycosides: ouabain with a concentration of 0.02%/g wet weight in the cerebrum shows the lowest and oleandrin with 1.60% the highest value. 3. By calculating the mean relative weights for the hearts (3.9 g/kg) and the brains (11.1 g/kg) 3.7% of the daily administered ouabain activity were found in the whole heart and only 0.18% in the whole brain. In contrast to these data the content of heart and brain after giving the more lipophilic oleandrin was 3.6% and 17.7% (!), respectively. 4. Under steady-state conditions the glycosides ouabain, digoxin, beta-methyldigoxin and digitoxin in heart and brain are mainly unchanged whereas oleandrin is transformed at a higher rate to polar metabolites.

摘要

用氚标记的物质研究了猫心脏和大脑中心脏活性糖苷的浓度。通过在5天内反复静脉注射哇巴因、地高辛、β - 甲基地高辛、洋地黄毒苷和夹竹桃苷来达到稳态。在最后一次给药5小时后,测量血浆、尿液、心脏、大脑和小脑的糖苷浓度。此外,还确定了这些部位的代谢模式。1. 每克湿重心脏中的糖苷浓度仅为每千克每日给药剂量的0.93%(夹竹桃苷)至1.88%(哇巴因)。2. 不同糖苷在大脑中的浓度差异更大:大脑中浓度为0.02%/克湿重的哇巴因显示出最低值,而夹竹桃苷浓度为1.60%,显示出最高值。3. 通过计算心脏(3.9克/千克)和大脑(11.1克/千克)的平均相对重量,发现整个心脏中每日给药哇巴因活性的3.7%,而整个大脑中仅为0.18%。与这些数据相反,给予亲脂性更强的夹竹桃苷后,心脏和大脑中的含量分别为3.6%和17.7%(!)。4. 在稳态条件下,心脏和大脑中的糖苷哇巴因、地高辛、β - 甲基地高辛和洋地黄毒苷主要未发生变化,而夹竹桃苷则以更高的速率转化为极性代谢物。

相似文献

1
[Concentration of cardiac glycosides in the heart and brain (author's transl)].心脏和大脑中强心苷的浓度(作者译)
Arzneimittelforschung. 1976;26(6):1213-6.
2
[Intestinal absorption of cardiac glycosides in vitro and in vivo].[强心苷在体外和体内的肠道吸收]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1969;262(1):53-72.
3
Concentration of digoxin, methyldigoxin, digitoxin and ouabain in the myocardium of the dog following coronary occulsion.冠状动脉闭塞后犬心肌中地高辛、甲基地高辛、洋地黄毒苷和哇巴因的浓度。
Naunyn Schmiedebergs Arch Pharmacol. 1975;287(4):399-411. doi: 10.1007/BF00500041.
4
Inotropic action, myocardial uptake and subcellular distribution of ouabain, digoxin and digitoxin in isolated rat hearts.哇巴因、地高辛和洋地黄毒苷在离体大鼠心脏中的变力作用、心肌摄取及亚细胞分布
Naunyn Schmiedebergs Arch Pharmacol. 1975;288(2-3):195-214. doi: 10.1007/BF00500527.
5
[Determination of the intestinal absorption of cardiac glycosides by measurement of 3H-labelled glycosides in the portal venous blood and in the intestinal lymph of cats].[通过测量猫门静脉血和肠淋巴液中3H标记的强心苷来测定强心苷的肠道吸收]
Naunyn Schmiedebergs Arch Pharmakol. 1969;264(4):406-19.
6
[Pharmacokinetics of digoxin and methyldigoxin in patients with acute hepatitis (author's transl)].急性肝炎患者地高辛和甲基地高辛的药代动力学(作者译)
Med Klin. 1978 Mar 31;73(13):463-9.
7
Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.强心甾体的研究。III. 不同强心苷在不同细胞外钾浓度下对收缩性和节律性的影响特征
Acta Biol Med Ger. 1975;34(6):1065-73.
8
[Metabolism of cardioactive glycosides].[强心苷的代谢]
Clin Ter. 1971 Apr 30;57(2):171-84.
9
The uptake and binding of six radiolabeled cardiac glycosides by guinea-pig hearts and by isolated sarcoplasmic reticulum.六种放射性标记强心苷在豚鼠心脏和分离的肌浆网中的摄取与结合。
J Pharmacol Exp Ther. 1968 Nov;164(1):10-21.
10
[On the determination of cardiotoxicity of cardiac glycosides in cats. 1. General bases and biophysical model for intravenous and intraduodenal infusion experiments].[关于猫体内强心苷心脏毒性的测定。1. 静脉内和十二指肠内输注实验的一般基础和生物物理模型]
Arzneimittelforschung. 1969 May;19(5):687-93.

引用本文的文献

1
Identification of a Cardiac Glycoside Exhibiting Favorable Brain Bioavailability and Potency for Reducing Levels of the Cellular Prion Protein.鉴定一种具有良好脑生物利用度和降低细胞朊病毒蛋白水平效力的心脏糖苷。
Int J Mol Sci. 2022 Nov 26;23(23):14823. doi: 10.3390/ijms232314823.
2
Cardiac glycoside-mediated turnover of Na, K-ATPases as a rational approach to reducing cell surface levels of the cellular prion protein.心脏糖苷介导的 Na,K-ATP 酶周转作为降低细胞表面细胞朊病毒蛋白水平的合理方法。
PLoS One. 2022 Jul 1;17(7):e0270915. doi: 10.1371/journal.pone.0270915. eCollection 2022.
3
Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein.
地高辛通过肠黏膜大量排泄,以及多药耐药蛋白1a(mdr 1a)P-糖蛋白防止地高辛在大脑中长期蓄积。
Br J Pharmacol. 1996 Nov;119(5):1038-44. doi: 10.1111/j.1476-5381.1996.tb15775.x.
4
Comparison of the pharmacokinetics of digoxin and dihydrodigoxin in cats in single-dose studies.猫单剂量研究中地高辛和二氢地高辛药代动力学的比较。
Naunyn Schmiedebergs Arch Pharmacol. 1978 Jun;303(2):181-7. doi: 10.1007/BF00508066.
5
beta-Methyl-digoxin. VIII. Relation of cerebral side-effects in cats to concentrations in the plasma and in the brain.β-甲基地高辛。VIII. 猫脑副作用与血浆及脑组织中浓度的关系。
Naunyn Schmiedebergs Arch Pharmacol. 1978 Mar;302(1):87-90. doi: 10.1007/BF00586602.
6
Pharmacokinetics of dihydrodigitoxin in the cat. A comparison with digitoxin.猫体内二氢地高辛的药代动力学。与地高辛的比较。
Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(2):147-53. doi: 10.1007/BF00500279.
7
Distribution of cardiac glycosides in heart and brain of dogs and their affinity to the (Na+ + K+)-ATPase.强心苷在犬心脏和大脑中的分布及其对(钠+钾)-ATP酶的亲和力。
Naunyn Schmiedebergs Arch Pharmacol. 1979 May;307(1):65-71. doi: 10.1007/BF00506553.